Literature DB >> 2555632

Neutrophil function and lipid peroxidation in a rat model of multiple organ failure.

I P van Bebber1, W K Boekholz, R J Goris, P H Schillings, H P Dinges, S Bahrami, H Redl, G Schlag.   

Abstract

Multiple organ failure (MOF) was induced by sterile intraperitoneal inoculation of zymosan in the rat. This results in a typical triphasic illness with maximal clinical signs at Days 2 and 14. In this study, granulocyte superoxide production (unstimulated and phorbol myristic acid stimulated) was studied as well as lipid peroxidation (TBAR) in plasma, liver, and lung tissue. Mainly TBAR levels in liver and lung tissue closely correlated with the triphasic clinical illness, while bacteriological data did not. It is concluded that the severe inflammatory response in this experimental model probably is the result of excessive toxic oxygen radical production. The first phase of illness may mainly be due to oxygen radical formation by activated PMN, the third phase of illness to the production of lysosomal enzymes (proteinases) from PMN, and activated macrophages as indicated by elevated N-acetylglucosaminidase levels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555632     DOI: 10.1016/0022-4804(89)90122-4

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

1.  Antioxidant diet protects against emphysema, but increases mortality in cigarette smoke-exposed mice.

Authors:  Toru Nyunoya; Thomas H March; Yohannes Tesfaigzi; JeanClare Seagrave
Journal:  COPD       Date:  2011-08-11       Impact factor: 2.409

2.  Prostaglandin synthetase inhibition reduces peritonitis-induced early liver oxidant stress.

Authors:  R Tokyay; E Kaya; E S Gur; P Tuncel; R Ozbek; E Ozturk
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  Hemoglobin toxicity in experimental bacterial peritonitis is due to production of reactive oxygen species.

Authors:  Y M Yoo; K M Kim; S S Kim; J A Han; H Z Lea; Y M Kim
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock.

Authors:  Stefania Marzocco; Rosanna Di Paola; Emanuela Mazzon; Tiziana Genovese; Domenico Britti; Aldo Pinto; Giuseppina Autore; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2005-03-15       Impact factor: 17.440

5.  Role of 5-lipoxygenase in the multiple organ failure induced by zymosan.

Authors:  Salvatore Cuzzocrea; Antonietta Rossi; Ivana Serraino; Rosanna Di Paola; Laura Dugo; Tiziana Genovese; Domenico Britti; Giuseppe Sciarra; Angelina De Sarro; Achille P Caputi; Lidia Sautebin
Journal:  Intensive Care Med       Date:  2004-07-06       Impact factor: 17.440

6.  Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study.

Authors:  Maria Galuppo; Rosanna Di Paola; Emanuela Mazzon; Tiziana Genovese; Concetta Crisafulli; Irene Paterniti; Elisabetta Cuzzocrea; Placido Bramanti; Amar Kapoor; Christoph Thiemermann; Salvatore Cuzzocrea
Journal:  J Inflamm (Lond)       Date:  2010-02-18       Impact factor: 4.981

7.  Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway.

Authors:  Seyhan Sahan-Firat; Meryem Temiz-Resitoglu; Demet Sinem Guden; Sefika Pinar Kucukkavruk; Bahar Tunctan; Ayse Nihal Sari; Zumrut Kocak; Kafait U Malik
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

Review 8.  Oxidative stress. Biochemistry and human disease.

Authors:  A Bast; R J Goris
Journal:  Pharm Weekbl Sci       Date:  1989-12-15

9.  Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects.

Authors:  C Szabó; L H Lim; S Cuzzocrea; S J Getting; B Zingarelli; R J Flower; A L Salzman; M Perretti
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.